SCHEMBL2108243

SCHEMBL2108243

O=C(O)c1cn(C2CC2)c2cc(Cl)c(F)cc2c1=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.64
KDM4E B2RXH2 5/20 0.64
TOP2A P11388 4/20 0.64
TOP2B Q02880 4/20 0.64
LMNA P02545 3/20 0.64
HPGD P15428 2/20 0.64
HSD17B10 Q99714 2/20 0.64
CYP1A2 P05177 1/20 0.64
CYP2C9 P11712 1/20 0.64
MAPT P10636 1/20 0.60
PIK3CG P48736 5/20 0.56
PIK3CD O00329 4/20 0.56
PIK3R1 P27986 4/20 0.56
PIK3CA P42336 4/20 0.56
POLB P06746 1/20 0.53
CHRM2 P08172 1/20 0.53
CHRM1 P11229 1/20 0.53
OPRM1 P35372 1/20 0.53
OPRD1 P41143 1/20 0.53
HTT P42858 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28459278 0.99 ALDH1A1 (0.62) ALDH1A1KDM4ETOP2ATOP2BLMNA
SCHEMBL541544 0.99 ALDH1A1 (0.62) ALDH1A1KDM4ETOP2ATOP2BLMNA
SCHEMBL541543 0.99 ALDH1A1 (0.62) ALDH1A1KDM4ETOP2ATOP2BLMNA
Oxalic Acid SCHEMBL27745929 0.96 ALDH1A1 (0.60) ALDH1A1KDM4ETOP2ATOP2BLMNA
SCHEMBL4718738 0.95 KDM4E (0.60) ALDH1A1KDM4ETOP2ATOP2BLMNA
SCHEMBL22506727 0.90 ALDH1A1 (0.52) ALDH1A1KDM4ETOP2ATOP2BLMNA
SCHEMBL501238 0.89 KDM4E (0.69) ALDH1A1KDM4ETOP2ATOP2BLMNA
SCHEMBL29442121 0.89 KDM4E (0.69) ALDH1A1KDM4ETOP2ATOP2BLMNA
SCHEMBL9844577 0.89 KDM4E (0.56) ALDH1A1KDM4ETOP2ATOP2BLMNA
SCHEMBL28750493 0.89 ALDH1A1 (0.56) ALDH1A1KDM4ETOP2ATOP2BLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 417 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115160224-B Preparation method and application of rare earth co-doped complex 江西师范大学 2024-08-06 CN claimed
CN-117362227-A Synthesis method of quinolone carboxylic ester 潍坊中农联合化工有限公司 2024-01-09 CN claimed
CN-109852377-B Seven-core Ln-Ba cluster crystalline material and preparation method and application thereof 江西师范大学 2023-03-21 CN claimed
US-11555016-B2 Pleuromulin 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ester with antibacterial activity and a method of preparing the same SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2023-01-17 US claimed
CN-115246814-A Synthetic method of fluoroquinolone antibacterial drugs 江苏开元药业有限公司 2022-10-28 CN claimed
CN-115160224-A Preparation method and application of novel rare earth co-doped complex 江西师范大学 2022-10-11 CN claimed
US-20220235008-A1 PLEUROMULIN 7-CHLORO-1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID ESTER WITH ANTIBACTERIAL ACTIVITY AND A METHOD OF PREPARING THE SAME SHAANXI UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2022-07-28 US claimed
CN-108659023-B Rare earth-potassium bimetallic complex with extremely high fluorescence quantum yield 江西师范大学 2021-10-01 CN claimed
CN-108976432-B Alkali metal modified lanthanide coordination polymer and preparation method and application thereof 江西师范大学 2021-09-07 CN claimed
CN-106008540-A Heterocyclic aromatic acid ester type podophyllotoxin derivatives with anti-tumor activity as well as preparation method and application 遵义医学院 2016-10-12 CN claimed
WO-2002085886-A2 CHIRAL, BROAD-SPECTRUM ANTIBACTERIAL 7-SUBSTITUTED PIPERIDINO-QUINOLONE CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND COMPOSITIONS WOCKHARDT LIMITED (IN) 2002-10-31 WO claimed
WO-1997020849-A1 CEPHALOSPORIN FLUOROQUINOLONATE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM LABORATORIOS ARANDA, S.A. DE C.V. (IT) 1997-06-12 WO claimed
EP-0274033-B1 PROCESS FOR THE PREPARATION OF QUINOLINECARBOXYLIC ACIDS BAYER AG (DE) 1992-03-11 EP claimed
US-5095112-A PROCESS FOR THE PREPARATION OF QUINOLONECARBOXYLIC ACID ESTERS BAYER AKTIENGESELLSCHAFT (DE) 1992-03-10 US claimed
EP-0274033-A1 Process for the preparation of quinolinecarboxylic acids BAYER AG (DE) 1988-07-13 EP claimed
CN-87107230-A Quinoline carboxylic acid's method for making 1988-07-06 CN claimed
US-4620007-A BACTERICIDES BAYER AKTIENGESELLSCHAFT (DE) 1986-10-28 US claimed
EP-0078362-B1 1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-PIPERAZINO-QUINOLINE-3-CARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION AND ANTIBACTERIAL AGENTS CONTAINING THEM BAYER AG (DE) 1986-10-22 EP claimed
EP-0113093-B1 1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-(ALKYL-1-PIPERAZINYL)-3-QUINOLINE-CARBOXYLIC ACIDS, PROCESS FOR THEIR PREPARATION AND ANTIBACTERIAL AGENTS CONTAINING THEM BAYER AG (DE) 1986-05-21 EP claimed
EP-0078362-A2 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-piperazino-quinoline-3-carboxylic acids, process for their preparation and antibacterial agents containing them BAYER AG (DE) 1983-05-11 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11555016-B2 Pleuromulin 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid ester with antibacterial activity and a method of preparing the same PLEC, MRPL21, MYADM ALDH1A1 183/4885KDM4E 4296/4885TOP2A 658/4885
US-20220235008-A1 PLEUROMULIN 7-CHLORO-1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACID ESTER WITH ANTIBACTERIAL ACTIVITY AND A METHOD OF PREPARING THE SAME PLEC, MRPL21, MYADM ALDH1A1 183/4885KDM4E 4296/4885TOP2A 658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.